Gregory J. Divis
Gregory J. Divis was named Chief Executive Ocer in June of 2019, after having served as Chief Operating Ocer (named in March 2018) and Executive Vice President and Chief Commercial Ocer (named in January 2017). Prior to joining Avadel, he served as an Executive in Residence at Linden Capital Partners, a healthcare-focused private equity rm. With over 25 years of experience in the pharmaceutical industry, Mr. Divis served as President and Chief Executive Ocer of Lumara Health, a specialty branded pharmaceutical company focused on women’s health. Prior to Lumara, Mr. Divis held general management, sales, marketing and business development roles at Schering Plough and Sano-Aventis.